178 related articles for article (PubMed ID: 37160933)
1. Autocitrullination confers monocyte chemotactic properties to peptidylarginine deiminase 4.
Yoshida K; Ito H; Kurosaka D; Ikeda R; Noda K; Saito M; Kurosaka D
Sci Rep; 2023 May; 13(1):7528. PubMed ID: 37160933
[TBL] [Abstract][Full Text] [Related]
2. Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3.
Damgaard D; Bawadekar M; Senolt L; Stensballe A; Shelef MA; Nielsen CH
PLoS One; 2018; 13(8):e0203214. PubMed ID: 30161253
[TBL] [Abstract][Full Text] [Related]
3. Citrulline Not a Major Determinant in the Recognition of Peptidylarginine Deiminase 2 and 4 by Autoantibodies in Rheumatoid Arthritis.
Darrah E; Davis RL; Curran AM; Naik P; Chen R; Na CH; Giles JT; Andrade F
Arthritis Rheumatol; 2020 Sep; 72(9):1476-1482. PubMed ID: 32255561
[TBL] [Abstract][Full Text] [Related]
4. High-Titer Rheumatoid Arthritis Antibodies Preferentially Bind Fibrinogen Citrullinated by Peptidylarginine Deiminase 4.
Blachère NE; Parveen S; Frank MO; Dill BD; Molina H; Orange DE
Arthritis Rheumatol; 2017 May; 69(5):986-995. PubMed ID: 28029744
[TBL] [Abstract][Full Text] [Related]
5. The monocyte cell surface is a unique site of autoantigen generation in rheumatoid arthritis.
Thomas MA; Naik P; Wang H; Giles JT; Girgis AA; Kim SY; Johnson TP; Curran AM; Crawford JD; Jahanbani S; Bingham CO; Robinson WH; Na CH; Darrah E
Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2304199121. PubMed ID: 38630712
[TBL] [Abstract][Full Text] [Related]
6. Peptidylarginine Deiminase Autoimmunity and the Development of Anti-Citrullinated Protein Antibody in Rheumatoid Arthritis: The Hapten-Carrier Model.
Auger I; Balandraud N; Massy E; Hemon MF; Peen E; Arnoux F; Mariot C; Martin M; Lafforgue P; Busnel JM; Roudier J
Arthritis Rheumatol; 2020 Jun; 72(6):903-911. PubMed ID: 31820586
[TBL] [Abstract][Full Text] [Related]
7. Macrophage extracellular traps require peptidylarginine deiminase 2 and 4 and are a source of citrullinated antigens bound by rheumatoid arthritis autoantibodies.
Bashar SJ; Holmes CL; Shelef MA
Front Immunol; 2024; 15():1167362. PubMed ID: 38476240
[TBL] [Abstract][Full Text] [Related]
8. Identification of potential autoantigens in anti-CCP-positive and anti-CCP-negative rheumatoid arthritis using citrulline-specific protein arrays.
Poulsen TBG; Damgaard D; Jørgensen MM; Senolt L; Blackburn JM; Nielsen CH; Stensballe A
Sci Rep; 2021 Aug; 11(1):17300. PubMed ID: 34453079
[TBL] [Abstract][Full Text] [Related]
9. Anti-peptidylarginine deiminase-4 antibodies at mucosal sites can activate peptidylarginine deiminase-4 enzyme activity in rheumatoid arthritis.
Demoruelle MK; Wang H; Davis RL; Visser A; Hoang J; Norris JM; Holers VM; Deane KD; Darrah E
Arthritis Res Ther; 2021 Jun; 23(1):163. PubMed ID: 34092252
[TBL] [Abstract][Full Text] [Related]
10. Defining the role of Porphyromonas gingivalis peptidylarginine deiminase (PPAD) in rheumatoid arthritis through the study of PPAD biology.
Konig MF; Paracha AS; Moni M; Bingham CO; Andrade F
Ann Rheum Dis; 2015 Nov; 74(11):2054-61. PubMed ID: 24864075
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
[TBL] [Abstract][Full Text] [Related]
12. Peptidylarginine deiminase 4 contributes to tumor necrosis factor α-induced inflammatory arthritis.
Shelef MA; Sokolove J; Lahey LJ; Wagner CA; Sackmann EK; Warner TF; Wang Y; Beebe DJ; Robinson WH; Huttenlocher A
Arthritis Rheumatol; 2014 Jun; 66(6):1482-91. PubMed ID: 24497204
[TBL] [Abstract][Full Text] [Related]
13. Protein Citrullination by Peptidyl Arginine Deiminase/Arginine Deiminase Homologs in Members of the Human Microbiota and Its Recognition by Anti-Citrullinated Protein Antibodies.
Pérez-Pérez ME; Nieto-Torres E; Bollain-Y-Goytia JJ; Delgadillo-Ruíz L
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791230
[TBL] [Abstract][Full Text] [Related]
14. Iguratimod dose dependently inhibits the expression of citrullinated proteins and peptidylarginine deiminases 2 and 4 in neutrophils from rheumatoid arthritis patients.
Li B; Li P; Bi L
Clin Rheumatol; 2020 Mar; 39(3):899-907. PubMed ID: 31758423
[TBL] [Abstract][Full Text] [Related]
15. Release of Active Peptidyl Arginine Deiminases by Neutrophils Can Explain Production of Extracellular Citrullinated Autoantigens in Rheumatoid Arthritis Synovial Fluid.
Spengler J; Lugonja B; Ytterberg AJ; Zubarev RA; Creese AJ; Pearson MJ; Grant MM; Milward M; Lundberg K; Buckley CD; Filer A; Raza K; Cooper PR; Chapple IL; Scheel-Toellner D
Arthritis Rheumatol; 2015 Dec; 67(12):3135-45. PubMed ID: 26245941
[TBL] [Abstract][Full Text] [Related]
16. Citrullination of epithelial neutrophil-activating peptide 78/CXCL5 results in conversion from a non-monocyte-recruiting chemokine to a monocyte-recruiting chemokine.
Yoshida K; Korchynskyi O; Tak PP; Isozaki T; Ruth JH; Campbell PL; Baeten DL; Gerlag DM; Amin MA; Koch AE
Arthritis Rheumatol; 2014 Oct; 66(10):2716-27. PubMed ID: 24943990
[TBL] [Abstract][Full Text] [Related]
17. Clinical and immunological aspects of anti-peptidylarginine deiminase type 4 (anti-PAD4) autoantibodies in rheumatoid arthritis.
Reyes-Castillo Z; Muñoz-Valle JF; Llamas-Covarrubias MA
Autoimmun Rev; 2018 Feb; 17(2):94-102. PubMed ID: 29196243
[TBL] [Abstract][Full Text] [Related]
18. Platelets derived citrullinated proteins and microparticles are potential autoantibodies ACPA targets in RA patients.
Xu M; Du R; Xing W; Chen X; Wan J; Wang S; Xiong L; Nandakumar KS; Holmdahl R; Geng H
Front Immunol; 2023; 14():1084283. PubMed ID: 36761728
[TBL] [Abstract][Full Text] [Related]
19. Heavy Chain Constant Region Usage in Antibodies to Peptidylarginine Deiminase 4 as a Marker of Disease Subsets in Rheumatoid Arthritis.
Gómez-Bañuelos E; Shi J; Wang H; Danila MI; Bridges SL; Giles JT; Sims GP; Andrade F; Darrah E
Arthritis Rheumatol; 2022 Nov; 74(11):1746-1754. PubMed ID: 35675168
[TBL] [Abstract][Full Text] [Related]
20. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.
Bawadekar M; Shim D; Johnson CJ; Warner TF; Rebernick R; Damgaard D; Nielsen CH; Pruijn GJM; Nett JE; Shelef MA
J Autoimmun; 2017 Jun; 80():39-47. PubMed ID: 28188029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]